You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,166,206


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,166,206 protect, and when does it expire?

Patent 10,166,206 protects NAFTIN and is included in one NDA.

This patent has three patent family members in three countries.

Summary for Patent: 10,166,206
Title:Topical compositions and methods for making and using same
Abstract: The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.
Inventor(s): Hardas; Bhushan (Summerville, NC), Dalton; Donna (High Point, NC), Scheppler; Petra (Mainz, DE), Buch; Anja (Eschborn, DE), Boderke; Peter (Schwalbach, DE)
Assignee: SEBELA INTERNATIONAL BERMUDA LIMITED (Hamilton, BM)
Application Number:15/255,464
Patent Claim Types:
see list of patent claims
Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,166,206: A Comprehensive Analysis

Introduction

Patent 10,166,206, like any other patent, is a complex document that outlines the scope and claims of an invention. To fully comprehend its implications, it is crucial to delve into the specifics of its claims, the patent landscape it operates within, and the relevant legal and practical considerations.

Patent Claims: An Overview

Patent claims are the heart of any patent application, defining the scope of the invention and what is protected under the patent. For U.S. patents, the claims must meet specific criteria to be considered patent-eligible, particularly under Section 101 of the U.S. Patent Act[2].

Claim Structure

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are critical in determining the patent's scope and are often used as a metric to measure patent breadth[5].
  • Dependent Claims: These claims refer back to and further limit the independent claims, providing additional details and narrowing the scope of the invention.

Subject Matter Eligibility

The 2024 USPTO guidance update on AI patent eligibility provides valuable insights into how claims are evaluated for subject matter eligibility. Key points include:

  • Integration into Practical Applications: Claims must integrate judicial exceptions (such as abstract ideas or natural phenomena) into practical applications to be considered patent-eligible. This involves assessing whether additional elements in the claim impose meaningful limits on the exception[1].
  • AI-Assisted Inventions: The method of invention development, including the use of AI, does not impact subject matter eligibility. The focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated equally with other technologies[1].

Practical Applications and Technological Improvements

To be patent-eligible, claims must demonstrate practical applications that provide tangible benefits. For example:

  • Real-Time Speech Recognition: A claim that specifies the use of separated audio components in a real-time speech recognition system to enhance the accuracy of voice commands in hands-free environments would be considered patent-eligible because it provides a practical application with clear benefits[1].

Inventorship and Ownership

Determining the true and only inventors is crucial for the validity of a patent. U.S. patent law requires that only the actual inventors be listed on the patent application. Incorrect or incomplete identification of inventors can lead to the patent being invalid or unenforceable[2].

Consequences of Incorrect Inventorship

  • Deceptive Intent: If there is deceptive intent in naming inventors, the patent can be found unenforceable. Even corrections after the fact may not rectify the issue if deceptive intent is proven[2].
  • Administrative and Legal Implications: Errors in inventorship can lead to administrative hassles and may raise red flags in future litigation, making it essential to get it right from the outset[2].

Patent Scope and Breadth

The scope of a patent is often debated in terms of its quality and impact on innovation. Metrics such as independent claim length and independent claim count can be used to measure patent scope:

  • Independent Claim Length: Longer independent claims may indicate a narrower scope, as they provide more detailed limitations.
  • Independent Claim Count: A higher number of independent claims can suggest a broader scope, but may also increase the complexity and potential for litigation[5].

The Role of Data in Patent Analysis

Datasets like the Patent Claims Research Dataset provided by the USPTO can offer detailed insights into patent claims and their trends. These datasets include claim-level statistics and document-level statistics, helping researchers and practitioners understand the scope and breadth of patents over time[3].

Legal and Policy Considerations

The legal and policy landscape surrounding patents is constantly evolving. For instance:

  • Small Claims Patent Court: There have been discussions and studies on the feasibility of a small claims patent court to address issues related to patent litigation costs and accessibility. Such a court could significantly impact how patent disputes are resolved, particularly for smaller entities[4].

Case Law and Recent Updates

Recent case law and updates, such as the 2024 USPTO guidance on AI patents, play a crucial role in shaping the patent landscape. These updates help practitioners draft claims that are more likely to avoid section 101 rejections and ensure that inventions are evaluated based on their technological improvements rather than the method of their development[1].

Key Takeaways

  • Practical Applications: Claims must integrate abstract ideas into practical applications to be patent-eligible.
  • Inventorship: Correct identification of inventors is paramount for the validity of a patent.
  • Patent Scope: Metrics such as claim length and count can help measure the scope and breadth of a patent.
  • Legal Updates: Recent guidance and case law significantly influence how patents are evaluated and enforced.

FAQs

What are the key criteria for a claim to be considered patent-eligible under the 2024 USPTO guidance?

A claim must integrate a judicial exception into a practical application, providing meaningful limits that transform the claim into patent-eligible subject matter[1].

How does the use of AI impact the patent eligibility of an invention?

The use of AI in the development of an invention does not affect its patent eligibility. The focus remains on the claimed invention itself, ensuring equal evaluation with other technologies[1].

What are the consequences of incorrect inventorship in a patent application?

Incorrect inventorship can lead to the patent being invalid or unenforceable, especially if there is deceptive intent. Corrections after the fact may not rectify the issue[2].

How can the scope of a patent be measured?

The scope can be measured using metrics such as independent claim length and independent claim count. These metrics provide insights into the breadth and clarity of the patent claims[5].

Is there a proposal for a small claims patent court in the U.S.?

Yes, there have been studies and discussions on the feasibility of a small claims patent court to address issues related to patent litigation costs and accessibility[4].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Determining Inventorship for US Patent Applications - Oregon State University
  3. Patent Claims Research Dataset - USPTO
  4. U.S. Patent Small Claims Court - ACUS
  5. Patent Claims and Patent Scope - SSRN

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,166,206

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sebela Ireland Ltd NAFTIN naftifine hydrochloride GEL;TOPICAL 204286-001 Jun 27, 2013 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,166,206

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014212201 ⤷  Subscribe
Canada 2899725 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2014121048 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.